(NNDC Members only) Join us for the Axsome Therapeutics Virtual Product Theatre – Two January Dates!
NNDC Members — Please join us for a virtual innovation theatre event featured at the NNDC Best Practices for Mood Disorders Conference this past fall! The session, “A Rapid-Acting Antidepressant that Modulates Glutamatergic and Monoaminergic Pathways,” will be presented by Paul Keck, MD, senior consultant and emeritus founding president and CEO, Lindner Center of HOPE, with registration available for two upcoming January dates!
A Rapid-Acting Antidepressant that Modulates Glutamatergic and Monoaminergic Pathways:
Session 1 | Monday, January 12, 2026 — 12:00-1:00 PM PST / 1:00-2:00 PM MST/ 2:00-3:00 PM CST/ 3:00-4:00 PM EST
Session 2 | Thursday, January 15, 2026 — 9:00-10:00 AM PST / 10:00-11:00 AM MST / 11:00-12:00 PM CST/ 12:00-1:00 PM EST
Scan the QR codes above or register for one of the sessions via the dates below, and we hope to see you there!
*NOTE: This event is for NNDC Members only and is not open to the public.